Merck licenses COMT inhibitors to Cerecor

Merck & Co. Inc. (NYSE:MRK) granted Cerecor Inc. (Baltimore, Md.) exclusive, worldwide rights to develop and commercialize preclinical catechol-O-methyltransferase ( COMT) inhibitors. Cerecor said it ...